Evaluation status available after sign-in
About the journal
Endocrine Oncology is an open-access journal published by Bioscientifica in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared review time at DOAJ: 26 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Bioscientifica
- ISSN
- 2634-4793
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Articles in DOAJ
- 146
- Declared review time
- 26 weeks
- Declared peer-review model
- other
- Official website
- https://journals.bioscientifica.com/eo
Index listings
- DOAJ · 2023-01-04
- PUBMED · 2023-01-01
- Indexing
- DOAJ · PUBMED
- APC
- —
- Declared review time (DOAJ)
- 26 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
146
Most recent article
last month
Average review time (journal-declared via DOAJ)
26weeks
Works in OpenAlex
189
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
11
i10-index
15
From OpenAlex open data (CC0).
Editorial & policy10
- Last DOAJ review date
- 2026-08-30
- Added to DOAJ
- 2023-01-04
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- Portico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 95%
- ORCID iDs in current deposits
- 94%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9918540584106676
Classification4
Subjects (DOAJ)
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinologyMedicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
LCC codes
RC648-665RC254-282
Subject areas
- Neuroendocrine Tumor Research Advances
- Neuroendocrine Tumor Research Advances
- Neuroendocrine Tumor Research Advances
- Pituitary Gland Disorders and Treatments
- Pituitary Gland Disorders and Treatments
- Adrenal and Paraganglionic Tumors
- Pituitary Gland Disorders and Treatments
- Adrenal and Paraganglionic Tumors
Show all subjects (75)
- Adrenal and Paraganglionic Tumors
- Estrogen and related hormone effects
- Thyroid Cancer Diagnosis and Treatment
- Thyroid Cancer Diagnosis and Treatment
- Thyroid Cancer Diagnosis and Treatment
- Estrogen and related hormone effects
- Prostate Cancer Treatment and Research
- Estrogen and related hormone effects
- Breast Cancer Treatment Studies
- Thyroid and Parathyroid Surgery
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Neuroblastoma Research and Treatments
- Neuroblastoma Research and Treatments
- Growth Hormone and Insulin-like Growth Factors
- Growth Hormone and Insulin-like Growth Factors
- Thyroid and Parathyroid Surgery
- Thyroid and Parathyroid Surgery
- Radiopharmaceutical Chemistry and Applications
- Prostate Cancer Treatment and Research
- Adrenal Hormones and Disorders
- Prostate Cancer Treatment and Research
- Growth Hormone and Insulin-like Growth Factors
- Thyroid Disorders and Treatments
- Metabolism, Diabetes, and Cancer
- Thyroid Disorders and Treatments
- Metabolism, Diabetes, and Cancer
- Neuroblastoma Research and Treatments
- Breast Cancer Treatment Studies
- Cancer Risks and Factors
- Thyroid Disorders and Treatments
- Pancreatic and Hepatic Oncology Research
- Hormonal Regulation and Hypertension
- Pancreatic and Hepatic Oncology Research
- Breast Cancer Treatment Studies
- HER2/EGFR in Cancer Research
- Cardiac tumors and thrombi
- HER2/EGFR in Cancer Research
- Glioma Diagnosis and Treatment
- Gastrointestinal Tumor Research and Treatment
- Pancreatic and Hepatic Oncology Research
- Hormonal Regulation and Hypertension
- Renal cell carcinoma treatment
- Gastrointestinal Tumor Research and Treatment
- Cancer, Hypoxia, and Metabolism
- Glioma Diagnosis and Treatment
- Cancer, Hypoxia, and Metabolism
- HER2/EGFR in Cancer Research
- Parathyroid Disorders and Treatments
- Cancer Risks and Factors
- Cardiac tumors and thrombi
- Gastrointestinal Tumor Research and Treatment
- Ear and Head Tumors
- Neurofibromatosis and Schwannoma Cases
- Cancer Risks and Factors
- Pancreatic function and diabetes
- Breast Lesions and Carcinomas
- Cancer-related Molecular Pathways
- Cancer Immunotherapy and Biomarkers
- Parathyroid Disorders and Treatments
- Human auditory perception and evaluation
- Adrenal Hormones and Disorders
- Endometrial and Cervical Cancer Treatments
- Endometrial and Cervical Cancer Treatments
- Parathyroid Disorders and Treatments
- Human auditory perception and evaluation
- Adrenal Hormones and Disorders
Keywords (DOAJ)
- cancer
- oncology
- hormones
- endocrinology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ